APC-8020

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAPC-8020
Drug Alias Name多发性骨髓瘤疫苗-DendreonMultiple myeloma vaccine - DendreonMyeloma vaccine - Dendreon骨髓瘤疫苗-DendreonMylovenge +[6] 
ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsAmyloidosisMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKirin Holdings Co LtdDendreon Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKirin Holdings Co LtdDendreon Corp
Active IndicationsN/A
Inactive IndicationsAmyloidosisMultiple Myeloma

Other Information

ATC CodeN/A
Related LinksN/A